Clinical Practice

Use the tool below to view all available Medtelligence Series

- George Bakris, MD
  Peer
- Biff F. Palmer, MD
  Peer
1
CME/CE
RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy Is NOT the Only Option
RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy Is NOT the Only Option
0.25 credits
RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy Is NOT the Only Op...
0.25 credits
- Ravindra L. Mehta, MD
  Peer
- Marlies Ostermann, MD
  Peer
20
Nephrology
KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice
KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice
KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute D...
- Ravindra L. Mehta, MD
  Peer
- Theresa Mottes, APRN-NP, CPNP-AC, CDN
  Peer
2
Nephrology
KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement
KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement
KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Qual...
- Erin D. Michos, MD, MHS, FACC, FAHA, FASE
  Peer
- James A. Underberg, MD
  Peer
- Nathan D. Wong, PhD, MPH
  Peer
3
CME/CE
Should EPA Be Another 'E' in the ABCs of CVD Risk Prevention? Straight Talk from the Experts
Should EPA Be Another 'E' in the ABCs of CVD Risk Prevention? Straight Talk from the Experts
0.50 credits
Should EPA Be Another 'E' in the ABCs of CVD Risk Prevention? Straight Talk f...
0.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Paul W. Armstrong, MD
  Peer
14
CME/CE
New Therapies Offer Improved Outcomes in HFrEF Management
New Therapies Offer Improved Outcomes in HFrEF Management
0.25 credits
New Therapies Offer Improved Outcomes in HFrEF Management
0.25 credits
- Azeem Latib, MD
  Peer
- Sarah Kohnstamm, MD, FACC
  Peer
7
CME/CE
Spotlight on New Guidelines to Identify and Manage Aortic Stenosis
Spotlight on New Guidelines to Identify and Manage Aortic Stenosis
0.50 credits
Spotlight on New Guidelines to Identify and Manage Aortic Stenosis
0.50 credits
- Jay S. Giri, MD, MPH
  Peer
- Renuka Jain, MD
  Peer
6
CME/CE
New Opportunities to Manage Aortic Stenosis with TAVR
New Opportunities to Manage Aortic Stenosis with TAVR
0.50 credits
New Opportunities to Manage Aortic Stenosis with TAVR
0.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
2
CME/CE
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei der Optimierung der RAASi-Therapie
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei der Optimierung der RAASi-Therapie
0.25 credits
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei de...
0.25 credits
- Gregory Lewis, MD
  Peer
- Michael Böhm, MD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
12
CME/CE
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
0.25 credits
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
- Gerasimos Filippatos, MD, FESC, FHFA
  Peer
6
CME/CE
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
0.25 credits
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
0.25 credits
- Michael Böhm, MD, FESC
  Peer
10
Global Heart Failure Academy
CARE HK bei HF: Entwurf einer Studie aus der Praxis zur Identifizierung von Barrieren für die leitliniengesteuerte RAASi-Therapie
CARE HK bei HF: Entwurf einer Studie aus der Praxis zur Identifizierung von Barrieren für die leitliniengesteuerte RAASi-Therapie
CARE HK bei HF: Entwurf einer Studie aus der Praxis zur Identifizierung von B...
- Stefan D. Anker, MD, PhD
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
11
Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
- George Bakris, MD
  Peer
- Matthew R. Weir, MD
  Peer
- Faiez Zannad, MD, PhD
  Peer
12
CME/CE
Potassium Management Made Easy
Potassium Management Made Easy
0.25 credits
Potassium Management Made Easy
0.25 credits
- Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
  Peer
- Mikhail Kosiborod, MD
  Peer
23
CME/CE
Management of Heart Failure: Time to Consider New Options?
Management of Heart Failure: Time to Consider New Options?
0.25 credits
Management of Heart Failure: Time to Consider New Options?
0.25 credits
- Michel Farnier, MD, PhD
  Peer
- Børge G. Nordestgaard, MD, DMSc
  Peer
8
CME/CE
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl (IPE)
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl (IPE)
0.75 credits
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl ...
0.75 credits
- Christopher P. Cannon, MD
  Peer
- Samuel Dagogo-Jack, MD, DSc
  Peer
12
CME/CE
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?
0.25 credits
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients wit...
0.25 credits

Popular

CME/CE

Nephrology

Nephrology

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Global Heart Failure Academy

Global Heart Failure Academy

CME/CE

CME/CE

CME/CE

CME/CE

NEED HELP?

Contact us

NEED HELP?

Contact us

Popular

CME/CE

Nephrology

Nephrology

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Global Heart Failure Academy

Global Heart Failure Academy

CME/CE

CME/CE

CME/CE

CME/CE

Title

NEED HELP?

Contact us

Share on ReachMD

Get a Dose of Medtelligence in Your Inbox and Practice Smarter Medicine